MENU
APLM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Apollomics (APLM) Ownership - Who owns Apollomics?

Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer... Show more

Profile

Industry
N/A
Address
989 East Hillsdale Boulevard
Phone
+1 650 209-4055
Employees
13
Web
https://www.apollomicsinc.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
50.14M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
4.72M
Revenue
N/A
Risk (Beta)
2.82
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
5.88 USD as % of share price
View a ticker or compare two or three
APLM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
989 East Hillsdale Boulevard
Phone
+1 650 209-4055
Employees
13
Web
https://www.apollomicsinc.com